1-8 of 8
Hong Huang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FBXO3-mediated DUSP9 ubiquitination reprograms MAPK signaling to eradicate tyrosine kinase inhibitor-resistant CML stem cells

Free
Xudong Li, Shiyu Zuo, Binglei Zhang, zhenghua huang, ruochen xu, mengjia li, Hong Huang, Yaomei Wang, Yongping Song, Baijun Fang, Bian Zhilei, Wei Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 3754.
https://doi.org/10.1182/blood-2025-3754
Published: 2025
Journal Articles

Venetoclax, cladribine plus low-dose cytarabine for relapsed/refractory Acute Myeloid Leukemia: A multicenter, randomized phase II Study

Free
Han-Yu Cao, Fangtong Liu, Kai-Wen Tan, Zi-Hao Wang, Si-Man Huang, Chao-Ling Wan, Yuan-Hong Huang, Mei-Jing Liu, Zhen Yao, Zheng Li, Ming-Zhu Xu, Hai-Xia Zhou, Haiping Dai, Shengli Xue
Journal: Blood
Blood (2025) 146 (Supplement 1): 5202.
https://doi.org/10.1182/blood-2025-5202
Published: 2025
Journal Articles

Bgb-11417: A novel BCL2 inhibitor with robust antileukemic activity in T-cell acute lymphoblastic leukemia, alone or with vincristine

Free
Hongfeng Pang, Chao-Ling Wan, Yuan-Hong Huang, Shuaishuai Ge, Chengqiao Qiu, Songbai Liu, Depei Wu, Haiping Dai, Shengli Xue
Journal: Blood
Blood (2025) 146 (Supplement 1): 6813.
https://doi.org/10.1182/blood-2025-6813
Published: 2025
Journal Articles

TIP-20: A novel FLT3 inhibitor with potent antileukemia activity

Free
Hongfeng Pang, Zhizhi Zhang, Yuan-Hong Huang, Chengqiao Qiu, Depei Wu, Shengli Xue, Songbai Liu
Journal: Blood
Blood (2025) 146 (Supplement 1): 6801.
https://doi.org/10.1182/blood-2025-6801
Published: 2025
Journal Articles

Decoding the Immune Microenvironment of Primary Chronic Myelomonocytic Leukemia and Secondary Chronic Myelomonocytic Leukemia Due to DLBCL with CD19 CAR-T Failure By Single-Cell RNA-Seq

Free
Xudong Li, Hong Huang, Binglei Zhang, Zhongxing Jiang, Yongping Song, Wenyi Lu, Bian Zhilei, Wei Li, Weijie Cao
Journal: Blood
Blood (2024) 144 (Supplement 1): 6695.
https://doi.org/10.1182/blood-2024-201202
Published: 2024
Journal Articles

Venetoclax with Hypomethylating Agents Compared with Priming Regimens for Newly Diagnosed Patients with Acute Myeloid Leukemia with Myelodysplasia Related Changes: A Single Center Retrospective Study

Free
Fangtong Liu, Chao-Ling Wan, Yu-Qing Liu, Yuan-Hong Huang, Han-Yu Cao, Si-Man Huang, Kai-Wen Tan, Shuai-Shuai Ge, Miao Wang, Mei-Jing Liu, Zihao Wang, Sheng-Li Xue, Haiping Dai
Journal: Blood
Blood (2024) 144 (Supplement 1): 1484.
https://doi.org/10.1182/blood-2024-202500
Published: 2024
Journal Articles

Venetoclax with Hypomethylating Agents Versus Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia with Myelodysplasia Related Changes: A Propensity Score Matched Analysis Based on International Consensus Classification

Free
Chao-Ling Wan, Yu-Qing Liu, Fang-Tong Liu, Yuan-Hong Huang, Han-Yu Cao, Si-Man Huang, Kai-Wen Tan, Zihao Wang, Shuai-Shuai Ge, Miao Wang, Haiping Dai, Sheng-Li Xue
Journal: Blood
Blood (2024) 144 (Supplement 1): 1527.
https://doi.org/10.1182/blood-2024-197933
Published: 2024
Journal Articles

RUNX1 Mutation Does Not Significantly Impact the Outcome of Newly Diagnosedadult AML: A Retrospective Study of Chinese AML Patients

Free
Chao-Ling Wan, Yuan-Hong Huang, Si-Man Huang, Tong-Tong Zhang, Kai-Wen Tan, Yan Qiu, Xiang-Dong Shen, Shuai-Shuai Ge, Han-Yu Cao, Yan-Yan Li, Songbai Liu, Qiao-Cheng Qiu, Haiping Dai, Sheng-Li Xue
Journal: Blood
Blood (2023) 142 (Supplement 1): 4216.
https://doi.org/10.1182/blood-2023-185390
Published: 2023